CG Oncology, Inc. Common stock (CGON) is a publicly traded Healthcare sector company. As of September 10, 2026, CGON trades at $72.01 with a market cap of $6.51B and a P/E ratio of -26.86. CGON moved +0.13% today. Year to date, CGON is +73.31%; over the trailing twelve months it is +115.00%. Its 52-week range spans $14.80 to $80.97. Analyst consensus is strong buy with an average price target of $91.80. Rallies surfaces CGON's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for CGON, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $72.01 |
| Market Cap | $6.51B |
| P/E Ratio | -26.86 |
| EPS | $-2.69 |
| Dividend Yield | 0.00% |
| 52-Week High | $80.97 |
| 52-Week Low | $14.80 |
| Volume | 103.22K |
| Avg Volume | 0 |
| Revenue (TTM) | $6.23M |
| Net Income | $-224.38M |
| Gross Margin | 0.00% |
10 analysts cover CGON: 0 strong buy, 10 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $91.80.